174 related articles for article (PubMed ID: 27874951)
1. High expression of long noncoding RNA Sox2ot is associated with the aggressive progression and poor outcome of gastric cancer.
Zou JH; Li CY; Bao J; Zheng GQ
Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4482-4486. PubMed ID: 27874951
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA SOX2OT contributes to gastric cancer progression by sponging miR-194-5p from AKT2.
Qu F; Cao P
Exp Cell Res; 2018 Aug; 369(2):187-196. PubMed ID: 29782828
[TBL] [Abstract][Full Text] [Related]
4. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
5. Overexpressed long noncoding RNA Sox2ot predicts poor prognosis for cholangiocarcinoma and promotes cell proliferation and invasion.
Li Z; Li J; Ji D; Leng K; Xu Y; Huang L; Jiang X; Cui Y
Gene; 2018 Mar; 645():131-136. PubMed ID: 29246536
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA CARLo-5 upregulation associates with poor prognosis in patients suffering gastric cancer.
Liu JN; Shangguan YM
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):530-534. PubMed ID: 28239816
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA microvascular invasion in hepatocellular carcinoma is an indicator of poor prognosis and a potential therapeutic target in gastric cancer.
Wang A; Du L; Jiang K; Kong Q; Zhang X; Li L
J Cancer Res Ther; 2019; 15(1):126-131. PubMed ID: 30880767
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of long non-coding RNA PCAT-1 correlates with tumor progression and poor prognosis in gastric cancer.
Cui WC; Wu YF; Qu HM
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3021-3027. PubMed ID: 28742205
[TBL] [Abstract][Full Text] [Related]
9. Elevated long non-coding RNA LINC00958 was associated with metastasis and unfavorable prognosis in gastric cancer.
Wang W; Song ZJ; Wang Y; Zhong WF; Kang P; Yang Y
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):598-603. PubMed ID: 30720167
[TBL] [Abstract][Full Text] [Related]
10. Upregulated expression of long non-coding RNA LINC00982 regulates cell proliferation and its clinical relevance in patients with gastric cancer.
Fei ZH; Yu XJ; Zhou M; Su HF; Zheng Z; Xie CY
Tumour Biol; 2016 Feb; 37(2):1983-93. PubMed ID: 26334618
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
Wang CY; Hua L; Yao KH; Chen JT; Zhang JJ; Hu JH
Int J Clin Exp Pathol; 2015; 8(1):779-85. PubMed ID: 25755774
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of long non-coding RNA SOX2OT in gastric adenocarcinoma.
Farhangian P; Jahandoost S; Mowla SJ; Khalili M
Cancer Biomark; 2018; 23(2):221-225. PubMed ID: 30198866
[TBL] [Abstract][Full Text] [Related]
13. The prognostic roles of long non-coding RNA SNHG17 in the patients with gastric cancer.
Chen LL; He J; Qiu XT; Yu J; Wang ZM
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1063-1068. PubMed ID: 30779073
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of long noncoding RNA PVT1 and its diagnostic and prognostic significance in patients with gastric cancer.
Yuan CL; Li H; Zhu L; Liu Z; Zhou J; Shu Y
Neoplasma; 2016; 63(3):442-9. PubMed ID: 26925791
[TBL] [Abstract][Full Text] [Related]
15. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of long noncoding RNA LINC00858 is associated with poor prognosis in gastric cancer.
Ai W; Li F; Yu HH; Liang ZH; Zhao HP
J Gene Med; 2020 Jul; 22(7):e3179. PubMed ID: 32119160
[TBL] [Abstract][Full Text] [Related]
17. Antisense Long Noncoding RNA HIF1A-AS2 Is Upregulated in Gastric Cancer and Associated with Poor Prognosis.
Chen WM; Huang MD; Kong R; Xu TP; Zhang EB; Xia R; Sun M; De W; Shu YQ
Dig Dis Sci; 2015 Jun; 60(6):1655-62. PubMed ID: 25686741
[TBL] [Abstract][Full Text] [Related]
18. High expression of long non-coding RNA CCAT2 indicates poor prognosis of gastric cancer and promotes cell proliferation and invasion.
Wu SW; Hao YP; Qiu JH; Zhang DB; Yu CG; Li WH
Minerva Med; 2017 Aug; 108(4):317-323. PubMed ID: 28248065
[TBL] [Abstract][Full Text] [Related]
19. Clinical prognostic value of A FOXM1 related long non-coding RNA expression in gastric cancer.
Chong DQ; Shan JL; Yang CS; Wang R; Du ZM
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):417-421. PubMed ID: 29424899
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer.
Peng W; Wu G; Fan H; Wu J; Feng J
Tumour Biol; 2015 Sep; 36(9):6751-8. PubMed ID: 25835973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
